Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Connective Tissue Growth Factor Inhibition Enhances Cardiac Repair and Limits Fibrosis After Myocardial Infarction.

Vainio LE, Szabó Z, Lin R, Ulvila J, Yrjölä R, Alakoski T, Piuhola J, Koch WJ, Ruskoaho H, Fouse SD, Seeley TW, Gao E, Signore P, Lipson KE, Magga J, Kerkelä R.

JACC Basic Transl Sci. 2019 Feb 25;4(1):83-94. doi: 10.1016/j.jacbts.2018.10.007. eCollection 2019 Feb.

2.

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.

Bell RJ, Rube HT, Kreig A, Mancini A, Fouse SD, Nagarajan RP, Choi S, Hong C, He D, Pekmezci M, Wiencke JK, Wrensch MR, Chang SM, Walsh KM, Myong S, Song JS, Costello JF.

Science. 2015 May 29;348(6238):1036-9. doi: 10.1126/science.aab0015. Epub 2015 May 14.

3.

Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.

van Thuijl HF, Mazor T, Johnson BE, Fouse SD, Aihara K, Hong C, Malmström A, Hallbeck M, Heimans JJ, Kloezeman JJ, Stenmark-Askmalm M, Lamfers ML, Saito N, Aburatani H, Mukasa A, Berger MS, Söderkvist P, Taylor BS, Molinaro AM, Wesseling P, Reijneveld JC, Chang SM, Ylstra B, Costello JF.

Acta Neuropathol. 2015 Apr;129(4):597-607. doi: 10.1007/s00401-015-1403-6. Epub 2015 Feb 28.

4.

Recurrent epimutations activate gene body promoters in primary glioblastoma.

Nagarajan RP, Zhang B, Bell RJ, Johnson BE, Olshen AB, Sundaram V, Li D, Graham AE, Diaz A, Fouse SD, Smirnov I, Song J, Paris PL, Wang T, Costello JF.

Genome Res. 2014 May;24(5):761-74. doi: 10.1101/gr.164707.113. Epub 2014 Apr 7.

5.

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.

Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF.

Science. 2014 Jan 10;343(6167):189-193. doi: 10.1126/science.1239947. Epub 2013 Dec 12.

6.

Response of primary glioblastoma cells to therapy is patient specific and independent of cancer stem cell phenotype.

Fouse SD, Nakamura JL, James CD, Chang S, Costello JF.

Neuro Oncol. 2014 Mar;16(3):361-71. doi: 10.1093/neuonc/not223. Epub 2013 Dec 4.

7.

Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells.

Sun MZ, Kim JM, Oh MC, Safaee M, Kaur G, Clark AJ, Bloch O, Ivan ME, Kaur R, Oh T, Fouse SD, Phillips JJ, Berger MS, Parsa AT.

Neuro Oncol. 2013 Nov;15(11):1518-31. doi: 10.1093/neuonc/not099. Epub 2013 Jul 25.

8.

Cancer Stem Cells Activate STAT3 the EZ Way.

Fouse SD, Costello JF.

Cancer Cell. 2013 Jun 10;23(6):711-3. doi: 10.1016/j.ccr.2013.05.016.

9.

Methods for cancer epigenome analysis.

Nagarajan RP, Fouse SD, Bell RJ, Costello JF.

Adv Exp Med Biol. 2013;754:313-38. doi: 10.1007/978-1-4419-9967-2_15. Review.

10.

Measuring patterns in team interaction sequences using a discrete recurrence approach.

Gorman JC, Cooke NJ, Amazeen PG, Fouse S.

Hum Factors. 2012 Aug;54(4):503-17.

PMID:
22908675
11.

VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.

Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G.

Cancer Cell. 2012 Jul 10;22(1):21-35. doi: 10.1016/j.ccr.2012.05.037.

12.

DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.

Craig JM, Vena N, Ramkissoon S, Idbaih A, Fouse SD, Ozek M, Sav A, Hill DA, Margraf LR, Eberhart CG, Kieran MW, Norden AD, Wen PY, Loda M, Santagata S, Ligon KL, Ligon AH.

PLoS One. 2012;7(6):e38881. doi: 10.1371/journal.pone.0038881. Epub 2012 Jun 15.

13.

The vividness of happiness in dynamic facial displays of emotion.

Becker DV, Neel R, Srinivasan N, Neufeld S, Kumar D, Fouse S.

PLoS One. 2012;7(1):e26551. doi: 10.1371/journal.pone.0026551. Epub 2012 Jan 11. Erratum in: PLoS One. 2012;7(5): doi/10.1371/annotation/f0519e8c-f347-4950-b7e8-3e9cbc3ec2a9.

14.

Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications.

Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O'Geen H, Lister R, Pelizzola M, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, Ecker JR, Li W, Farnham PJ, Waterland RA, Meissner A, Marra MA, Hirst M, Milosavljevic A, Costello JF.

Nat Biotechnol. 2010 Oct;28(10):1097-105. doi: 10.1038/nbt.1682. Epub 2010 Sep 19.

15.

Genome-scale DNA methylation analysis.

Fouse SD, Nagarajan RO, Costello JF.

Epigenomics. 2010 Feb;2(1):105-17. doi: 10.2217/epi.09.35. Review.

16.

Conserved role of intragenic DNA methylation in regulating alternative promoters.

Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, Turecki G, Delaney A, Varhol R, Thiessen N, Shchors K, Heine VM, Rowitch DH, Xing X, Fiore C, Schillebeeckx M, Jones SJ, Haussler D, Marra MA, Hirst M, Wang T, Costello JF.

Nature. 2010 Jul 8;466(7303):253-7. doi: 10.1038/nature09165.

17.

Epigenetics of neurological cancers.

Fouse SD, Costello JF.

Future Oncol. 2009 Dec;5(10):1615-29. doi: 10.2217/fon.09.132. Review.

18.

Genome-wide DNA methylation profiling: the mDIP-chip technology.

Shen Y, Fouse SD, Fan G.

Methods Mol Biol. 2009;568:203-16. doi: 10.1007/978-1-59745-280-9_13.

PMID:
19582429
19.

Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation.

Fouse SD, Shen Y, Pellegrini M, Cole S, Meissner A, Van Neste L, Jaenisch R, Fan G.

Cell Stem Cell. 2008 Feb 7;2(2):160-9. doi: 10.1016/j.stem.2007.12.011.

20.

X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations.

Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, Xu R, Pellegrini M, Riggs AD, Fan G.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4709-14. doi: 10.1073/pnas.0712018105. Epub 2008 Mar 13.

21.

Epigenetic regulation of neural gene expression and neuronal function.

Feng J, Fouse S, Fan G.

Pediatr Res. 2007 May;61(5 Pt 2):58R-63R. Review.

PMID:
17413844
22.

DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling.

Fan G, Martinowich K, Chin MH, He F, Fouse SD, Hutnick L, Hattori D, Ge W, Shen Y, Wu H, ten Hoeve J, Shuai K, Sun YE.

Development. 2005 Aug;132(15):3345-56.

23.

DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.

Martinowich K, Hattori D, Wu H, Fouse S, He F, Hu Y, Fan G, Sun YE.

Science. 2003 Oct 31;302(5646):890-3.

Supplemental Content

Support Center